Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
19,607,843
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
736,307
-
Shares change
-
+17,413
-
Total reported value, excl. options
-
$9,887,632
-
Value change
-
+$230,057
-
Number of buys
-
8
-
Number of sells
-
-7
-
Price
-
$13.43
Significant Holders of Annovis Bio, Inc. - Common Stock, par value $0.0001 per share (ANVS) as of Q4 2022
23 filings reported holding ANVS - Annovis Bio, Inc. - Common Stock, par value $0.0001 per share as of Q4 2022.
Annovis Bio, Inc. - Common Stock, par value $0.0001 per share (ANVS) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 736,307 shares
of 19,607,843 outstanding shares and own 3.8% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (242,571 shares), BlackRock Inc. (103,196 shares), GEODE CAPITAL MANAGEMENT, LLC (43,558 shares), Merit Financial Group, LLC (43,150 shares), Wescott Financial Advisory Group, LLC (41,607 shares), Bank of New York Mellon Corp (34,223 shares), Redmond Asset Management, LLC (34,010 shares), Sterling Investment Advisors, Ltd. (32,474 shares), Modera Wealth Management, LLC (30,513 shares), and MORGAN STANLEY (29,656 shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.